Related Experiment Video

Updated: Jul 4, 2026

Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
08:41

Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction

Published on: January 12, 2016

Arsenic trioxide decreases AKT protein in a caspase-dependent manner

Koren K Mann1, Myrian Colombo, Wilson H Miller

  • 1Lady Davis Institute for Medical Research, Segal Cancer Center, McGill University, Montreal, Quebec, Canada.

Molecular Cancer Therapeutics
|June 21, 2008
PubMed

Insights

Arsenic trioxide (As2O3) reduces AKT protein levels, enhancing its cytotoxicity via the JNK pathway. This finding suggests As2O3 combination therapies for cancers with high AKT activity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Arsenic trioxide (As2O3) treats acute promyelocytic leukemia but shows limited efficacy in other cancers.
  • Understanding As2O3-induced cytotoxicity pathways is crucial for developing novel combination therapies.
  • A reactive oxygen species-mediated, SEK1/c-Jun NH2-terminal kinase (JNK) pathway is essential for As2O3-induced apoptosis.

Purpose of the Study:

  • To investigate the role of AKT in As2O3-induced cytotoxicity.
  • To elucidate the mechanism by which As2O3 affects AKT activity and expression.
  • To identify potential therapeutic targets for enhancing As2O3 efficacy.

Main Methods:

  • Assessed As2O3 effects on AKT activity and protein levels in cancer cells.
  • Investigated the correlation between AKT protein decrease and As2O3 sensitivity.
  • Utilized caspase and proteasome inhibitors to determine the mechanism of AKT degradation.
  • Examined the impact of heat shock protein 90 (HSP90) inhibitors in combination with As2O3.

Main Results:

  • As2O3 decreases both AKT activity and total AKT protein levels.
  • Reduced AKT protein levels correlate with increased As2O3 sensitivity and JNK pathway activation.
  • As2O3 induces AKT degradation via caspase-mediated pathways, not proteasomal degradation.
  • Combining As2O3 with an HSP90 inhibitor enhances AKT downregulation and growth inhibition.

Conclusions:

  • As2O3-induced cytotoxicity involves the downregulation of AKT protein stability.
  • Caspase-mediated degradation is the primary mechanism for As2O3-induced AKT loss.
  • As2O3 may be effective in combination therapies targeting AKT signaling or in tumors with high AKT expression.

More Related Videos

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis12:55

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on: February 16, 2015

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...